Pursuit Vascular comes within shouting distance of a $1.6 million funding goal for its ClearGuard device for reducing catheter infections.
Pursuit Vascular is close to reaching a $1.6 million funding goal, having raised $1.57 million, according to a regulatory filing.
Minneapolis-based Pursuit Vascular is devleoping technology for reducing catheter infections, including the ClearGuard platform that's designed to cut infections associated with hemodialysis catheters.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1fyhxru
Cap comentari:
Publica un comentari a l'entrada